1. Academic Validation
  2. Cyclen-based Gd3+ complexes as MRI contrast agents: Relaxivity enhancement and ligand design

Cyclen-based Gd3+ complexes as MRI contrast agents: Relaxivity enhancement and ligand design

  • Bioorg Med Chem. 2016 Nov 15;24(22):5663-5684. doi: 10.1016/j.bmc.2016.09.069.
Haroon Ur Rashid 1 Marco Antonio Utrera Martines 2 Juliana Jorge 2 Paula Martin de Moraes 2 Muhammad Naveed Umar 3 Kamin Khan 4 Hanif Ur Rehman 4
Affiliations

Affiliations

  • 1 Department of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Khyber Pakhtunkhwa, Pakistan; Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil. Electronic address: haroongold@gmail.com.
  • 2 Institute of Chemistry, Federal University of Mato Grosso do Sul, Campo Grande, MS, Brazil.
  • 3 Department of Chemistry, University of Malakand, Chakdara, Lower Dir, Khyber Pakhtunkhwa, Pakistan.
  • 4 Department of Chemistry, Sarhad University of Science and Information Technology, Peshawar, Khyber Pakhtunkhwa, Pakistan.
Abstract

Magnetic Resonance Imaging (MRI) is a noninvasive radiology technique used to examine the internal organs of human body. It is useful for the diagnosis of structural abnormalities in the body. Contrast agents are used to increase the sensitivity of this technique. 1,4,7,10-Tetraazacyclododecane (cyclen) is a macrocyclic tetraamine. Its derivatives act as useful ligands to produce stable complexes with Gd3+ ion. Such chelates are investigated as MRI contrast agents. Free Gd3+ ion is extremely toxic for in vivo use. Upon complexation with a cyclen-based ligand, it is trapped in the preformed central cavity of the ligand resulting in the formation of a highly stable Gd3+-chelate. Better kinetic and thermodynamic stability of cyclen-based MRI contrast agents decrease their potential toxicity for in vivo use. Consequently, such agents have proved to be safest for clinical applications. Relaxivity is the most important parameter used to measure the effectiveness of a contrast agent. A number of factors influence this parameter. This article elucidates detailed strategies to increase relaxivity of cyclen-based MRI contrast agents. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid (DO3A) are two key ligands derived from cyclen. They also act as building blocks for the synthesis of novel ligands. A few important methodologies for the synthesis of DOTA and DO3A derivatives are described. Moreover, the coordination geometry of chelates formed by these ligands and their derivatives is discussed as well. Novel ligands can be developed by the appropriate derivatization of DOTA and DO3A. Gd3+-chelates of such ligands prove to be useful MRI contrast agents of enhanced relaxivity, greater stability, better clearance, lesser toxicity and higher water solubility.

Keywords

Chelate; Contrast agent; Cyclen; Gadolinium; Octadentate; Relaxivity.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-W007656
    99.94%, Macrocyclic Chelates Intermediate